Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sugen LLC

Latest From Sugen LLC

Novartis Is Dialing Out Of Its Listed Indian Arm – The Possibilities

Novartis initiates strategic review of listed Indian entity including taking a call on its 70.68% shareholding. Industry pundits point to potential suitors and options that may be at play.

Commercial India

Arcus’s CD73 Inhibitor Could Turn ‘Cold’ Pancreatic Cancer ‘Hot’

There are promising early signals from the novel mechanism, but Arcus’ fortunes remain tied to results from the TIGIT field.

Clinical Trials ImmunoOncology

India CEO Pay: Up, Up For Most, Eye On Gender Pay Gap As Women Execs Rise

C-suite remuneration at leading listed foreign and domestic drug firms in India rose in double digits for the most part in 2022-23, data compiled by Scrip show. While MDs/CEOs at domestic firms continue to take home sizeably higher earnings, the arrival of women leaders at the helm in some foreign firms puts the spotlight on gender pay parity.

Commercial Leadership

Astellas’s Venture Arm Is Focused On Flexibility But Avoiding Hype

VC Playbook: Bradley Hardiman, senior director of business development at Astellas Venture Management, discusses setting a CVC strategy when the biopharma market is in a “state of flux.”  

VC Playbook Business Strategies
See All

Company Information